"Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2019" Published

New Pharmaceuticals market report from GlobalData: "Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2019"
By: Fast Market Research, Inc.
 
Aug. 25, 2012 - PRLog -- Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2019

Summary

GlobalData, the industry analysis specialist, has released its new report, "Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2019". The report is an essential source of information and analysis on the global Hepatitis A Preventive Vaccines market. The report identifies the key trends shaping and driving the global Hepatitis A Preventive Vaccines market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Hepatitis A Preventive Vaccines sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/prod/434859_hepatitis_a_preventive_...
------------------------------------------------------------

Scope

The report provides information on the key drivers and challenges of the Hepatitis A Preventive Vaccines market. Its scope includes -

* Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Hepatitis A Preventive Vaccines market revenues data from 2006 to 2011, forecast for eight years to 2019.
* Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
* Analysis of the current and future competition in the seven key countries Hepatitis A Preventive Vaccines market.
* Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
* Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Hepatitis A Preventive Vaccines market.
* Analysis of key recent licensing and partnership agreements in Hepatitis A Preventive Vaccines market

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

* Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
* Develop business strategies by understanding the trends shaping and driving the global Hepatitis A Preventive Vaccines market.
* Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Hepatitis A Preventive Vaccines market in future.
* Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
* Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
* Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
* What's the next big thing in the global Hepatitis A Preventive Vaccines market landscape? - Identify, understand and capitalize.

Companies Mentioned in this Report: GlaxoSmithKline, Merck & Co, Crucell

Partial Table of Contents:

1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Hepatitis A Introduction
2.1 Disease Overview
2.2 Epidemiology
2.2.1 Historical Vaccination Coverage (2006-2011)
2.2.2 Forecast Vaccination Coverage (2011-2019)
2.3 Prognosis
2.4 Etiology
2.5 Pathophysiology
2.6 Signs and Symptoms
2.7 Diagnosis
2.8 Treatment and Management Options
2.9 Referral Pathway
2.10 GlobalData Pipeline Report Guidance
3 Hepatitis A Preventive Vaccines - Market Characterization
3.1 Global Hepatitis A Preventive Vaccines Market Size (2006-2011)
3.2 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - Global
3.3 Hepatitis A Preventive Vaccines Market Size (2006-2011) - The US
3.4 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - The US
3.5 Hepatitis A Preventive Vaccines Market Size (2006-2011) - France
3.6 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - France
3.7 Hepatitis A Preventive Vaccines Market Size (2006-2011) - Germany
3.8 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - Germany
3.9 Hepatitis A Preventive Vaccines Market Size (2006-2011) - Italy
3.10 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - Italy
3.11 Hepatitis A Preventive Vaccines Market Size (2006-2011) - Spain
3.12 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - Spain
3.13 Hepatitis A Preventive Vaccines Market Size (2006-2011) - The UK
3.14 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - The UK
3.15 Hepatitis A Preventive Vaccines Market Size (2006-2011) - Japan
3.16 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - Japan
3.17 Drivers and Barriers for the Hepatitis A Preventive Vaccines Market
3.17.1 Drivers for the Hepatitis A Preventive Vaccines Market
3.17.2 Barriers for the Hepatitis A Preventive Vaccines Market
3.18 Opportunity and Unmet Need Analysis
3.19 Key Takeaway
4 Hepatitis A Preventive Vaccines - Competitive Assessment
4.1 Overview
4.2 Strategic Competitor Assessment
4.3 Product Profiles for the Major Marketed class of Products in the Hepatitis A Market
4.3.1 Havrix
4.3.2 Vaqta
4.3.3 Twinrix
4.3.4 Ambirix
4.3.5 Avaxim
4.3.6 Epaxal
4.4 Key Takeaway
5 Hepatitis A Preventive Vaccines - Clinical Trials Mapping

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=4348...

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team.
End
Source:Fast Market Research, Inc.
Email:***@fastmr.com Email Verified
Zip:01267
Tags:Hepatitis, Preventive, Vaccine
Industry:Medical
Location:Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Fast Market Research News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share